[정치]Busy Securing Crown Vaccine “Effort to Protect 30 Million People”



[ad_1]

Prime Minister Jeong Sye-gyun “Promoting More Than 30 Million Vaccines”
“Even if you have a contract with a company, there is no guarantee that 100% will be supplied”
“Complex factors like price, timing, distribution, etc. need patience”
“UK AstraZeneca, one of the most important supply lines for the government”


[앵커]

Amid growing interest in insuring the Korean government’s COVID-19 vaccine, Prime Minister Jeong Sye-gyun said he is making efforts to insure more than 30 million people, which the government has proposed as a target amount.

However, even if they signed a contract with a vaccine provider, there is no guarantee that they will be 100% successful.

Reporter Hwang Hye-kyung reports.

[기자]

Questions about obtaining the Corona 19 vaccine also came up at the government emergency meeting.

Prime Minister Jeong Sye-gyun drew a line that the ruling party was referring to “promoting the safety of 44 million people,” saying it was not without foundation, but it was not the government’s final draft.

However, he explained that he is trying to insure more than 30 million people to obtain a target amount of 30 million people because there is no guarantee that he will be supplied 100% even if he has a contract with a bio-company.

[정세균 / 국무총리 : 3상을 잘 하고 있다가도 이게 마지막 단계에서 무산될 수도 있죠. 그럴 경우에는 사실은 선급금만 지급하고 백신은 공급받지 못하는 사례도 발생할 수 있는 것입니다. 그렇기 때문에 백신을 구매하는 상대처를 한두 곳으로 정하지 않고 위험을 분산하는 노력도 하는 것이고요.]

We plan to report the results to the public as soon as possible, but we emphasize that we are cautious with disclosure because complex factors such as pricing conditions, timing of supply, and expiration date are at play.

[정세균 / 국무총리 : 공급선에서 부르는 가격대로 그들이 제시하는 조건대로 하려고 하면 진작에 벌써 끝났죠. (그렇지만 우리 질병청에서는) 어떻게든지 개선해서 우리한테 유리한 결론을 도출하기 위해서 현재 노력을 하고 있는 거예요. 인내심을 가지고 좀 기다려주십사하는 말씀을 드리고요.]

It is one of the important supply lines that the government thinks of the UK’s ‘AstraZeneca’, which is controversial because it was only half the amount, but the effect is greater. It may be delayed, but it will not be a decisive problem.

He also explained that he is providing administrative support along with the budget for national biological companies that are conducting vaccine research.

This is YTN Hwang Hye-kyung.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]
[ad_2]